EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors

Annalisa Comandatore, Gregorio Di Franco, Ingrid Garajová, Afrodita Panaitescu, Fabio Ausania, Livia Giannessi, Niccoló Furbetta, Simone Guadagni, Anna Caterina Milanetto, Claudio Pasquali, Manuel Gentiluomo, Chiara Corradi und 4 weitere

Seminars in Cancer Biology · 2025

DOI: 10.1016/j.semcancer.2025.06.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Annalisa Comandatore und 15 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; Depar…. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Pancreatic Intraductal Neoplasms. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondazione Pisa, Associazione Italiana per la Ricerca sul Cancro, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrence of IPMNs after surgical resection is defined as the reappearance of new cystic lesions, invasive carcinoma, or metastases, either in the remnant pancreas or other distant sites. The median 5-year cumulative incidence of residual pancreatic lesions is 10 % (range, 0-21 %) and this risk continues to increase even after five years, especially in patients with the presence of HGD at first surgery and a family history of pancreatic ductal adenocarcinoma (PDAC). The management algorithm for all IPMNs is described in the latest guidelines on IPMNs; the patient's general condition, comorbidities, and life expectancy should be considered as well in the surgical decision. All patients operated for IPMN, have a risk of developing metachronous pancreatic lesions, which may require further surgery. Therefore, postoperative surveillance should be continued until the patient is surgically fit. The primary objective of this review is to evaluate the current scientific evidence regarding the management and surveillance strategies in patients who have undergone surgery for IPMN. Secondarily, we assessed the definitions of recurrence after surgery and explored the clinical, pathological, and biomolecular factors which may influence the biologic behavior of IPMNs. The optimal surveillance strategy for resected IPMN remains a topic of ongoing debate. The presence of an enlarging mass, the increase of ductal diameter, extrapancreatic disease observed during postoperative CT scans were previously taken into account as possible recurrence indicators. Additionally, positive resection margins, tumor invasiveness, and lymph node involvement were previously correlated with recurrence, while the role of molecular biomarkers still needs to bevalidated. This underscores the importance of rigorous, long-term follow-up, with multimodal approach as recurrent IPMNs can be detected even more than five years post-surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalCarcinoma, Pancreatic DuctalPancreatic NeoplasmsPancreatic Intraductal NeoplasmsHumansPrognosisPancreatectomyBiomarkers, Tumor

Stichwörter der Autor:innen

Biologic predictors of recurrenceIPMNLong term recurrencePDACRecurrent IPMNResected IPMN

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy; Department of Medical Oncology, Cancer Center Amsterdam, University Medical…
  • General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy.
  • Medical Oncology Unit, University Hospital of Parma, Parma 43126, Italy.
  • Gastroenterology and Interventional Endoscopy Department, Bucharest Clinical Emergency Hospital, Bucharest, Romania.
  • Department of HBP and Transplant Surgery, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, C/ Villarroel 170, Barcelona 08036, Spain.
  • Department of Medical Oncology, Cancer Center Amsterdam, University Medical Center, Amsterdam 1081, the Netherlands.

Förderung

  • Fondazione Pisa
  • Associazione Italiana per la Ricerca sul Cancro
  • European Cooperation in Science and Technology

Zitieren

APA

Comandatore, A., Di Franco, G., Garajová, I., Panaitescu, A., Ausania, F., Giannessi, L., Furbetta, N., Guadagni, S., Milanetto, A. C., Pasquali, C., Gentiluomo, M., Corradi, C., Adsay, V., Campa, D., Giovannetti, E., & Morelli, L. (2025). Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.06.001

Vancouver

Comandatore A, Di Franco G, Garajová I, Panaitescu A, Ausania F, Giannessi L, et al. Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.06.001

BibTeX
@article{Comandatore2025,
  author = {Comandatore, Annalisa and Di Franco, Gregorio and Garajová, Ingrid and Panaitescu, Afrodita and Ausania, Fabio and Giannessi, Livia and Furbetta, Niccoló and Guadagni, Simone and Milanetto, Anna Caterina and Pasquali, Claudio and Gentiluomo, Manuel and Corradi, Chiara and Adsay, Volkan and Campa, Daniele and Giovannetti, Elisa and Morelli, Luca},
  title = {Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  doi = {10.1016/j.semcancer.2025.06.001}
}
Kostenlos starten →